Tag Archives: Big Pharma
Prior Authorizations: Proportionate measure or burden without benefit?
Pamela White advocates for strong consumer protection regulation of health insurance company use of prior authorizations.
Pharmacare: Improving Access to Expensive Drugs
Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.
Responding to the Opioid Epidemic
Matthew Herder considers possible regulatory responses to the opioid epidemic that aim to recover health care costs, compensate survivors, or prosecute pharmaceutical companies.
Using Social Media to Sell Prescription Drugs
Jean-Christophe Bélisle-Pipon and Stanislav Birko consider how direct-to-consumer marketing of prescription drugs using social media might be prevented by amending Canada’s Food and Drug Regulations.
Margaret Lock Offers Dementia’s Realism Instead of Hope
Cynthia Martin writes that unlike cancer’s new push to accelerate treatment (recently launched under the banner Cancer Moonshot2020), there is no Alzheimer’s MoonShot2020.
Impact Ethics 